BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6047184)

  • 1. [Pyrazinamide, cycloserine and ethionamide in the complex treatment of pulmonary tuberculosis].
    Aspevik E
    Tidsskr Nor Laegeforen; 1967 Mar; 87(6):548-54. PubMed ID: 6047184
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR
    Bull Int Union Tuberc; 1968 Dec; 41():175-7. PubMed ID: 4885379
    [No Abstract]   [Full Text] [Related]  

  • 3. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
    Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
    Bernard E
    Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
    [No Abstract]   [Full Text] [Related]  

  • 5. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D
    Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
    [No Abstract]   [Full Text] [Related]  

  • 6. [Administration of reserve antitubercular drugs in a single daily dose].
    Bek E; Bukalska Z; Zachara A
    Gruzlica; 1968; 37(1):43-7. PubMed ID: 5720037
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison among single, double and triple drug regimens in retreatment. (the seventh series of the trial, B)].
    Kekkaku; 1968 Jun; 43(6):199-207. PubMed ID: 5701828
    [No Abstract]   [Full Text] [Related]  

  • 8. [The course and results of treatment of pulmonary tuberculosis as a function of the dosage of Pyrazinamide].
    Malinowska B; Pawlak F
    Gruzlica; 1970; 38(6):531-5. PubMed ID: 4317029
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of urogenital tuberculosis].
    König K
    Urologe; 1970 Jan; 9(1):44. PubMed ID: 5461516
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR; Lind A; Rist N
    Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo studies to assess the suitability of anti-tuberculous drugs for use in intermittent chemotherapy regimens.
    Dickinson JM
    Bull Int Union Tuberc; 1968 Dec; 41():309-15. PubMed ID: 4179554
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of patients with drug-resistance in economically developed countries.
    Crofton J
    Tubercle; 1969 Mar; 50():Suppl:65-8. PubMed ID: 4319134
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
    Steininger WJ
    Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
    Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
    Aoyagi T; Fukuhara Y; Hondo G; Matsumiya T; Murata A
    Kekkaku; 1970 Jan; 45(1):27-36. PubMed ID: 5416951
    [No Abstract]   [Full Text] [Related]  

  • 18. Report on experiences with ethambutol.
    Böszörményi M
    Antibiot Chemother; 1970; 16():292-3. PubMed ID: 5535615
    [No Abstract]   [Full Text] [Related]  

  • 19. [Concentration of ethionamide and cycloserine in the blood of the patients with pulmonary tuberculosis].
    Ivanova ES
    Antibiotiki; 1967 Aug; 12(8):727-32. PubMed ID: 4968419
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect and toxicity on the combined use of pyrazinamide, ethionamide and kanamycin in the retreatment of pulmonary tuberculosis (author's transl)].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):199-200. PubMed ID: 555425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.